Investigating brain changes in Alzheimer's disease using neuroimaging biomarkers

Development and evaluation of neuroimaging biomarkers of structural and functional network degeneration in Alzheimer’s disease

['FUNDING_FELLOWSHIP'] · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · NIH-11070571

This study is looking at how changes in the brain are connected to Alzheimer's disease, with the goal of finding better ways to track and diagnose the condition using advanced brain scans.

Quick facts

Phase['FUNDING_FELLOWSHIP']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF TEXAS HLTH SCIENCE CENTER (nih funded)
Locations1 site (SAN ANTONIO, UNITED STATES)
Trial IDNIH-11070571 on ClinicalTrials.gov

What this research studies

This research focuses on understanding how structural and functional changes in the brain relate to Alzheimer's disease. By utilizing advanced neuroimaging techniques, the study aims to develop new biomarkers that can better reflect the progression of the disease. The approach involves creating models based on existing data and validating them with new brain imaging from patients at different stages of Alzheimer's. This could lead to improved methods for diagnosing and monitoring the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, those with mild cognitive impairment, and healthy individuals for comparison.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnosis and monitoring of Alzheimer's disease, ultimately improving patient care.

How similar studies have performed: Similar approaches have shown success in other neurological conditions, suggesting potential for this method in Alzheimer's research.

Where this research is happening

SAN ANTONIO, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.